11 June 2012 - Lorus Therapeutics Inc. (TSX:LOR), a clinical stage cancer drug development company, has announced today that it has completed its earlier announced private placement of 20,625,000 units.

The units are priced at a subscription price of USD0.32 per unit. Each unit includes one...

 

 

 

You must be logged in to view the whole article.
Click here if you require signing up